Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia Disorder
NCT04573725
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Insomnia Disorder
Interventions
DRUG:
TS-142
DRUG:
Dose-matched Placebo to TS-142
Sponsor
Taisho Pharmaceutical Co., Ltd.